BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chuang SC, Hashibe M, Scelo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Dresler CM, Boffetta P, Brennan P. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008;17:1543-1549. [PMID: 18559572 DOI: 10.1158/1055-9965.epi-07-2876] [Cited by in Crossref: 59] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 van de Ven S, Bugter O, Hardillo JA, Bruno MJ, Baatenburg de Jong RJ, Koch AD. Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis. United European Gastroenterol J 2019;7:1304-11. [PMID: 31839955 DOI: 10.1177/2050640619856459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jang BI, Hwang MJ. Do Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal Neoplasms? Gut Liver 2016;10:6-7. [PMID: 26696025 DOI: 10.5009/gnl15564] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wang SH, Chi CC, Zhao ZH, Tung TH. Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study. Cancer Res Treat 2018;50:428-35. [PMID: 28494532 DOI: 10.4143/crt.2017.110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and prognostic significance of second primary cancers in renal cell carcinoma. Am J Clin Oncol 2013;36:132-42. [PMID: 22441339 DOI: 10.1097/COC.0b013e3182438ddf] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
5 Baeg MK, Choi MG, Jung YD, Ko SH, Lim CH, Kim HH, Kim JS, Cho YK, Park JM, Lee IS, Kim SW. Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal Neoplasms. Gut Liver 2016;10:76-82. [PMID: 25963088 DOI: 10.5009/gnl14381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Wen XD, Wen DG, Yang Y, Shan BE, Wang SJ. Earlier onset and multiple primaries in familial as opposed to sporadic esophageal cancer. World J Med Genet 2014; 4(2): 39-45 [DOI: 10.5496/wjmg.v4.i2.39] [Reference Citation Analysis]
7 Shimizu D, Koike M, Kanda M, Sonohara F, Hattori N, Hayashi M, Tanaka C, Yamada S, Kodera Y. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus. Surg Today 2021;51:153-8. [PMID: 32638131 DOI: 10.1007/s00595-020-02072-w] [Reference Citation Analysis]
8 Lin JD, Lin KJ, Chao TC, Hseuh C, Tsang NM, Huang BY. Clinical presentations of thyroid cancer patients with multiple primary cancers. J Endocrinol Invest 2011;34:824-30. [PMID: 21613811 DOI: 10.3275/7747] [Reference Citation Analysis]
9 Colonna M, Mitton N, Bossard N, Belot A, Grosclaude P. Total and partial cancer prevalence in the adult French population in 2008. BMC Cancer. 2015;15:153. [PMID: 25884310 DOI: 10.1186/s12885-015-1168-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
10 Lee KD, Lu CH, Chen PT, Chan CH, Lin JT, Huang CE, Chen CC, Chen MC. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 2009;9:373. [PMID: 19843324 DOI: 10.1186/1471-2407-9-373] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
11 Bermejo JL, Sundquist J, Hemminki K. Bladder cancer in cancer patients: population-based estimates from a large Swedish study. Br J Cancer 2009;101:1091-9. [PMID: 19755987 DOI: 10.1038/sj.bjc.6605325] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
12 Otowa Y, Nakamura T, Takiguchi G, Urakawa N, Ishida R, Imanishi T, Suzuki S, Tanaka K, Kuroda D, Kakeji Y. Successful treatment of quintuple primary cancer, including esophageal cancer: A case report. Oncol Lett 2015;9:2583-5. [PMID: 26137110 DOI: 10.3892/ol.2015.3082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Mitani S, Kadowaki S, Oze I, Masuishi T, Narita Y, Bando H, Oonishi S, Hirayama Y, Tanaka T, Tajika M, Koide Y, Kodaira T, Abe T, Muro K. Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis. Cancer Med 2020;9:394-400. [PMID: 31730285 DOI: 10.1002/cam4.2688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 van de Ven SEM, Falger JM, Verhoeven RHA, Baatenburg de Jong RJ, Spaander MCW, Bruno MJ, Koch AD. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population. United European Gastroenterol J 2021;9:497-506. [PMID: 33270530 DOI: 10.1177/2050640620977129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chen SC, Teng CJ, Hu YW, Yeh CM, Hung MH, Hu LY, Ku FC, Tzeng CH, Chiou TJ, Chen TJ, Liu CJ. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study. PLoS One 2015;10:e0116384. [PMID: 25635388 DOI: 10.1371/journal.pone.0116384] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
16 Satomi T, Kawano S, Inaba T, Nakagawa M, Mouri H, Yoshioka M, Tanaka S, Toyokawa T, Kobayashi S, Tanaka T, Kanzaki H, Iwamuro M, Kawahara Y, Okada H. Efficacy and safety of endoscopic submucosal dissection for gastric tube cancer: A multicenter retrospective study. World J Gastroenterol 2021; 27(11): 1043-1054 [PMID: 33776371 DOI: 10.3748/wjg.v27.i11.1043] [Reference Citation Analysis]
17 Liu Y, Chen H, Sun Z, Chen X. Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma. Cancer Lett 2015;361:164-73. [PMID: 25766659 DOI: 10.1016/j.canlet.2015.03.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
18 Zhang M, Yang X, Chen S, Jia W, Ma X, Wang J, Qian Y, Lei D, Liu H, Pan X. GPR12 inhibits migration and promotes apoptosis in esophageal cancer and hypopharyngeal cancer cells. Thorac Cancer 2021;12:1525-35. [PMID: 33742771 DOI: 10.1111/1759-7714.13933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas. J Community Hosp Intern Med Perspect 2017;7:238-40. [PMID: 29046751 DOI: 10.1080/20009666.2017.1369377] [Reference Citation Analysis]
20 Mackay CJ, Chen Y. Ruptured cerebral abscess with ventriculitis and leptomeningitis; A rare complication in the setting of metastatic esophageal cancer: Case report and literature review. Radiol Case Rep 2019;14:782-5. [PMID: 31011379 DOI: 10.1016/j.radcr.2019.03.034] [Reference Citation Analysis]
21 Chang CC, Bi KW, Lin HJ, Su YC, Wang WL, Lin CY, Ting CF, Sun MF, Huang ST. Conventional Western Treatment Associated With Chinese Herbal Medicine Ameliorates the Incidence of Head and Neck Cancer Among Patients With Esophageal Cancer. Integr Cancer Ther 2019;18:1534735419834353. [PMID: 30866690 DOI: 10.1177/1534735419834353] [Reference Citation Analysis]
22 Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25-43. [PMID: 30171414 DOI: 10.1007/s10388-018-0642-8] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 29.3] [Reference Citation Analysis]
23 Murakami Y, Hamai Y, Emi M, Hihara J, Imano N, Takeuchi Y, Takahashi I, Nishibuchi I, Kimura T, Okada M, Nagata Y. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma. J Radiat Res 2018;59:616-24. [PMID: 29939306 DOI: 10.1093/jrr/rry047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Huang B, Xiong F, Wang S, Lang X, Wang X, Zhou H. Effect of SATB1 silencing on the proliferation, invasion and apoptosis of TE-1 esophageal cancer cells. Oncol Lett 2017;13:2915-20. [PMID: 28521398 DOI: 10.3892/ol.2017.5854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Vasile MI, Mogoantă SŞ, Vîlcea DI, Mirea CS, Albulescu DM, Dumitrescu TV, Popescu M, Moraru E. Squamous Esophageal Carcinoma Synchronous to Pericolic Malignant Conjunctive Tumor. Curr Health Sci J 2017;43:282-6. [PMID: 30595890 DOI: 10.12865/CHSJ.43.03.17] [Reference Citation Analysis]
26 Li L, Zhang X, Zhang ZT. Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis. Int J Genomics 2019;2019:2789035. [PMID: 31886162 DOI: 10.1155/2019/2789035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Xie SH, Wahlin K, Lagergren J. Cause of death in patients diagnosed with esophageal cancer in Sweden: a population-based study. Oncotarget 2017;8:51800-9. [PMID: 28881689 DOI: 10.18632/oncotarget.15270] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
28 Lee KD, Wang TY, Lu CH, Huang CE, Chen MC. The bidirectional association between oral cancer and esophageal cancer: A population-based study in Taiwan over a 28-year period. Oncotarget 2017;8:44567-78. [PMID: 28562351 DOI: 10.18632/oncotarget.17818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
29 Lee JS, Ahn JY, Choi KD, Song HJ, Kim YH, Lee GH, Jung HY, Ryu JS, Kim SB, Kim JH, Park SI, Cho KJ, Kim JH. Synchronous second primary cancers in patients with squamous esophageal cancer: Clinical features and survival outcome. Korean J Intern Med. 2016;31:253-259. [PMID: 26864297 DOI: 10.3904/kjim.2014.182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
30 Morita M, Saeki H, Ito S, Kimura Y, Yamashita N, Ando K, Hiyoshi Y, Tokunaga E, Oki E, Ikeda T, Yoshida S, Nakashima T, Maehara Y. Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today 2014;44:1603-10. [PMID: 23989943 DOI: 10.1007/s00595-013-0713-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]